The Recall Desk
HighFDA (Drugs)·D-833-2015·Announced 2015-04-29

Attix Pharmaceuticals Recalls Paroxetine Active Ingredient Due to Penicillin Cross-Contamination Risk

Attix Pharmaceuticals is recalling paroxetine active pharmaceutical ingredient repackaged between January 2012 and February 2015 due to potential penicillin cross-contamination.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: The recall involves a high-risk allergen (penicillin) cross-contamination in a pharmaceutical product where no illnesses have been reported, fitting the rubric criteria for a score of 3.

Plain-English summary

Attix Pharmaceuticals is recalling all lots of paroxetine active pharmaceutical ingredient (API) packaged in bags or drums. The affected product was repackaged and distributed between January 5, 2012, and February 12, 2015.

The recall was initiated because the product was repackaged in a facility that also handled penicillin products without adequate separation. This process created a potential for cross-contamination with penicillin. The FDA has classified this as a Class II recall.

The product was distributed nationwide to compounding pharmacies and research organizations. There are no reported illnesses or injuries associated with this recall. Consumers and healthcare providers should stop using the affected product and contact their supplier or the recalling firm for instructions on return or disposal.

The recalled product

Product
Paroxetine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 470 recalled by Attix Pharmaceuticals under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 470 products in this recall →